BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33637051)

  • 1. Hepatitis C viraemic and seroprevalence and risk factors for positivity in Northwest Cambodia: a household cross-sectional serosurvey.
    Lynch E; Falq G; Sun C; Bunchhoeung PDT; Huerga H; Loarec A; Dousset JP; Marquardt T; Paih ML; Maman D
    BMC Infect Dis; 2021 Feb; 21(1):223. PubMed ID: 33637051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C seroprevalence among people living with HIV/AIDS and pregnant women in four provinces in Cambodia: an integrated bio-behavioral survey.
    Pheng P; Meyer L; Ségéral O; Chea P; Yi S; Tuot S; Kaldor JM; Saphonn V
    BMC Infect Dis; 2022 Feb; 22(1):177. PubMed ID: 35193496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of hepatitis C virus infection in Punjab, India: A population-based serosurvey.
    Sood A; Suryaprasad A; Trickey A; Kanchi S; Midha V; Foster MA; Bennett E; Kamili S; Alvarez-Bognar F; Shadaker S; Surlikar V; Garg R; Mittal P; Sharma S; May MT; Vickerman P; Averhoff F
    PLoS One; 2018; 13(7):e0200461. PubMed ID: 30048454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination.
    Hagan LM; Kasradze A; Salyer SJ; Gamkrelidze A; Alkhazashvili M; Chanturia G; Chitadze N; Sukhiashvili R; Shakhnazarova M; Russell S; Blanton C; Kuchukhidze G; Baliashvili D; Hariri S; Ko S; Imnadze P; Drobeniuc J; Morgan J; Averhoff F
    BMC Public Health; 2019 May; 19(Suppl 3):480. PubMed ID: 32326913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis C virus infection according to the year of birth: identification of risk groups.
    Neukam K; Ridruejo E; Pérez P; Campos RH; Martínez AP; Di Lello FA
    Eur J Clin Microbiol Infect Dis; 2018 Feb; 37(2):247-254. PubMed ID: 29076048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demographic determinants of hepatitis C virus seroprevalence among blood donors.
    Murphy EL; Bryzman S; Williams AE; Co-Chien H; Schreiber GB; Ownby HE; Gilcher RO; Kleinman SH; Matijas L; Thomson RA; Nemo GJ
    JAMA; 1996 Apr; 275(13):995-1000. PubMed ID: 8596257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence and risk factors for hepatitis B and hepatitis C in three large regions of Kazakhstan.
    Nersesov A; Gusmanov A; Crape B; Junusbekova G; Berkinbayev S; Jumabayeva A; Kaibullayeva J; Madenova S; Novitskaya M; Nazarova M; Gaipov A; Ashimkhanova A; Kadyrzhanuly K; Atageldiyeva K; Vento S; Issanov A
    PLoS One; 2021; 16(12):e0261155. PubMed ID: 34914773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence, viremia and genotype distribution of hepatitis C virus: a community-based population study in northern Italy.
    Campello C; Poli A; Dal MG; Besozzi-Valentini F
    Infection; 2002 Jan; 30(1):7-12. PubMed ID: 11876521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional survey of the extent and indicators of hepatitis C virus infection in Houston Department of Health and Human Services' sexually transmitted disease clinics.
    D'Souza G; Arafat R; Hwang L; Cunningham C; Shah S; Reynolds K
    J Viral Hepat; 2003 Mar; 10(2):134-40. PubMed ID: 12614470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group.
    Dubois F; Desenclos JC; Mariotte N; Goudeau A
    Hepatology; 1997 Jun; 25(6):1490-6. PubMed ID: 9185773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global prevalence of hepatitis C virus in women of childbearing age in 2019: a modelling study.
    Dugan E; Blach S; Biondi M; Cai Z; DePaola M; Estes C; Feld J; Gamkrelidze I; Kottilil S; Ma S; Mathur P; Montoya S; Razavi-Shearer D; Razavi-Shearer K; Robbins-Scott S; Schmelzer J; Razavi H
    Lancet Gastroenterol Hepatol; 2021 Mar; 6(3):169-184. PubMed ID: 33515496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence and risk factors for HIV, HCV, HBV and syphilis among blood donors in Mali.
    Jary A; Dienta S; Leducq V; Le Hingrat Q; Cisse M; Diarra AB; Fofana DB; Ba A; Baby M; Achenbach CJ; Murphy R; Calvez V; Marcelin AG; Maiga AI
    BMC Infect Dis; 2019 Dec; 19(1):1064. PubMed ID: 31856758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening.
    De Weggheleire A; An S; De Baetselier I; Soeung P; Keath H; So V; Ros S; Teav S; Smekens B; Buyze J; Florence E; van Griensven J; Thai S; Francque S; Lynen L
    PLoS One; 2017; 12(8):e0183530. PubMed ID: 28832660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costing analysis of field implementation of hepatitis C case detection in rural Maung Russey operational district, Cambodia.
    Han SM; Por I; Samley K; Bunreth V; Smith C; Ariyoshi K; Dousset JP; Le Paih M
    Western Pac Surveill Response J; 2021; 12(3):17-24. PubMed ID: 34703632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Decrease of HCV seroprevalence in Mexico: Results from the National Health and Nutrition Survey 2012].
    Gutiérrez JP; Sucilla-Pérez H; Conde-González CJ; Izazola JA; Romero-Martínez M; Hernández-Ávila M
    Salud Publica Mex; 2016; 58(1):25-32. PubMed ID: 26879504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus seroprevalence in the Netherlands.
    Vriend HJ; Op de Coul EL; van de Laar TJ; Urbanus AT; van der Klis FR; Boot HJ
    Eur J Public Health; 2012 Dec; 22(6):819-21. PubMed ID: 22461704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
    Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
    Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatitis C virus infection among pregnant women in a rural district in Egypt.
    Khamis HH; Farghaly AG; Shatat HZ; El-Ghitany EM
    Trop Doct; 2016 Jan; 46(1):21-7. PubMed ID: 25515736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global prevalence of hepatitis C virus in children in 2018: a modelling study.
    Schmelzer J; Dugan E; Blach S; Coleman S; Cai Z; DePaola M; Estes C; Gamkrelidze I; Jerabek K; Ma S; Montoya S; Razavi-Shearer D; Razavi-Shearer K; Robbins-Scott S; Razavi H; El Sayed MH
    Lancet Gastroenterol Hepatol; 2020 Apr; 5(4):374-392. PubMed ID: 31954439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania.
    Voiculescu M; Iliescu L; Ionescu C; Micu L; Ismail G; Zilisteanu D; Radasan A; Micu G; Pertache I
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):43-8. PubMed ID: 20361074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.